GCGashaw Sisay Chanie

Gashaw Sisay Chanie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gashaw Sisay Chanie has a total of 68 co-authors. Here are the top co-authors by number of shared publications:

  • Zemenu Wube Bayleyegn

    Department of Social and Administrative Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

    5 shared publications
  • Alemante Tafese Beyna

    Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia, uog.edu.et

    4 shared publications
  • Assefa Kebad Mengesha

    Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

    4 shared publications
  • Wudneh Simegn

    Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Adelaide, South Australia, Australia.

    4 shared publications
  • Abdulwase Mohammed

    Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

    3 shared publications
  • Eyayaw Ashete Belachew

    3 shared publications

Latest Publications

  • Open Access

    Survival and predictors of major adverse cardiovascular events among patients with acute coronary syndrome in Ethiopia: a retrospective cohort study

    by Gebremariam Wulie Geremew, Abaynesh Fentahun Bekalu, Gebresilassie Tadesse, Setegn Fentahun, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Gashaw Sisay Chanie, Sisay Sitotaw Anberbr, Habtamu Semagne Ayele, Assefa Kebad Mengesha, et al.

    Objectives: To determine the time to major adverse cardiovascular events (MACE) and identify its predictors among patients with acute coronary syndrome (ACS) discharged on secondary prevention medications in Ethiopia. Design: Institution-based retrospective cohort study. Setting: University of Gondar Comprehensive Specialized Hospital, Northwest, Ethiopia. Participants: A total of 400 adult patients diagnosed with ACS and discharged with secondary prevention medications between January 2020 and December 2024. Outcome measures: The primary outcome was time to first MACE, defined as reinfarction, stroke or heart failure, measured in years from hospital discharge. A Cox proportional hazards regression model was fitted to identify predictors of time to develop MACE. Data collected from patient medical charts were exported to STATA V.17 for analysis. The log-rank test was used to determine the survival difference between subgroups of participants. Results: During follow-up, 33.8% of patients experienced at least one MACE. The median time to MACE was 1.5 years. Female sex (adjusted HR (AHR)=2.08; 95% CI 1.24 to 3.49), presence of chronic comorbidities (AHR=2.09; 95% CI 1.42 to 4.41) and higher Killip class (IV vs I: AHR=1.57; 95% CI 1.22 to 1.78) were independently associated with a shorter time to MACE. Patients aged ≤55 years had a lower risk of MACE compared with those aged ≥66 years (AHR=0.77; 95% CI 0.54 to 0.98). Conclusions: Among patients with ACS discharged on secondary prevention medications, one-third experienced MACE within a median of 1.5 years. Older age, female sex, presence of comorbidities and higher Killip class were significant predictors of shorter time to MACE. These findings highlight the need for targeted postdischarge monitoring and secondary prevention strategies, particularly in resource-limited settings.

  • Open Access

    Pharmacy students’ insights on assessment tools and their predictive value in evaluating clinical competencies

    by Adeladlew Kassie Netere, Ashenafi Kibret Sendekie, Gashaw Sisay Chanie, Eyayaw Ashete Belachew

    Introduction: Competency-based pharmacy education (CBPE) emphasizes patient-centred care and clinical accountability, requiring the translation of core competencies into measurable learning outcomes supported by effective assessment strategies. Within this framework, both formative and summative assessments are essential. However, evaluating clinical competence remains challenging due to the limitations of current methods. Understanding of students’ perspectives is therefore crucial for refining these strategies. This study explores pharmacy students’ perceptions of assessment tools and their perceived effectiveness in evaluating clinical competencies at the University of Gondar. Method: A cross-sectional survey was conducted among graduating pharmacy clerkship students at the College of Medicine and Health Sciences, University of Gondar, Ethiopia, who had completed a one-year clinical attachment across multiple medical wards. Data were collected in August 2022 using a structured, self-administered face-to-face questionnaire. The survey explored students’ perceptions of assessment instruments and approaches used within the competency-based pharmacy curriculum. Descriptive statistics and comparative analyses were conducted across multiple assessment instruments to evaluate perceived difficulty, fairness, degree of learning, and frequency of use, using the Friedman test. Result: Of the 135 students approached, 118 participated (response rate 87%). Approximately 64% were regular fifth-year undergraduate pharmacy students in the clerkship program. The formative assessment approach was perceived to enhance confidence (68%) and motivation to study (64%). In the summative assessment domain, 52% of students agreed or strongly agreed that continuous assessment is a fairer method for evaluating academic performance compared to one-off exams. About 50% of students rely primarily on question-spotting as their strategy for preparing for written exams. Furthermore, 47% and 46% agreed and strongly agreed that module grades often depend too heavily on written exams, and that study materials were excessively demanding, respectively. Also, many students (68%) agreed on the utility and objectivity of the Objective Structured Clinical Examination (OSCE) in assessing clinical competencies; they rated it as difficult to perform. Conclusion: This survey showed that students view formative assessments as helpful for enhancing learning, motivation, and confidence. In contrast, summative assessments mainly decide grades through a single examination. Although many students found OSCE stations challenging, these tools were considered effective for evaluating clinical skills. These results offer valuable insights into students’ experiences with different assessment methods and can inform the selection and improvement of assessment strategies in competency-based pharmacy education.

  • Open Access

    Safety of Dolutegravir-Based Regimens in Adults with HIV: A Systematic Review and Meta-Analytic Synthesis of Clinical and Real-World Evidence

    by Gashaw Sisay, Eyayaw Ashete Belachew, Wondim Ayenew, Yilkal Abebaw Wassie, Yonas Sisay Aragie, Daniela Fialova

    Background: Dolutegravir (DTG)-based regimens are globally recommended as first-line antiretroviral therapy for people living with HIV (PLHIV), yet real-world evidence suggests variability in adverse drug events (ADEs). We synthesized available clinical and pharmacoepidemiological evidence to estimate the pooled prevalence and associated factors of ADEs among adults receiving DTG-based therapy. Methods: This systematic review and meta-analysis were registered in PROSPERO (CRD42023486384) and conducted following PRISMA 2020 guidelines. We searched major databases for observational studies reporting ADEs in adults on DTG-based regimens up to June 29, 2025. Two reviewers independently screened studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale. Random-effects meta-analysis (DerSimonian–Laird) was used to estimate pooled prevalence. Heterogeneity was assessed using I2 and subgroup analyses by region and study design. Publication bias was evaluated using Egger’s and Begg’s tests. Findings: Twelve studies involving diverse geographic regions were included. The pooled prevalence of ADEs among adults receiving DTG-based regimens was 2.70% (95% CI: 1.98–3.68), with substantial heterogeneity across studies. Gastrointestinal and neuropsychiatric events were the most frequently reported adverse effects. Subgroup analyses showed significant variation by geographic region and study design, although heterogeneity remained high within subgroups. Evidence of publication bias was explored and adjusted where necessary. Interpretation: DTG-based regimens demonstrate overall good tolerability; however, clinically relevant gastrointestinal and neuropsychiatric adverse events persist and vary across settings. Standardized pharmacovigilance systems and routine monitoring particularly for vulnerable populations are essential to optimize long-term treatment safety and adherence.

  • Open Access

    Patients Reported Adverse Effects of Antidepressants Among Depressive Disorder and Associated Risk Factors: A Multicenter Cross‐Sectional Study

    by Gashaw Sisay Chanie, Gebremariam Wulie Geremew, Alemante Tafese Beyna, Melshew Fenta Misker, Habtamu Semagne Ayele, Abebe Worku Teshager, Girma Medfu Takele, Gizachew Kassahun Bizuneh, Jember Azanaw, Eyayaw Ashete Belachew, et al.

    Background: Over the last two decades, antidepressant usage has seen a notable rise. Following the initiation of antidepressant medication, numerous patients experience adverse drug reactions. The main objective of this research was to determine the adverse effects of antidepressants, and identify the associated factors for outpatients who had been diagnosed with depression in three chosen clinics specializing in psychiatry in Ethiopia. Methods: A prospective multicenter cross‐sectional study was carried out from June 12, 2024, to November 13, 2024, involving a total of 422 participants. An antidepressant side effect checklist (ASEC) was employed to evaluate side effects, and unstructured questionnaires were reviewed through interviews conducted with patients and their caregivers. The data collected were analyzed using the Statistical Package for the Social Sciences (SPSS), version 26.0. A descriptive summary of the data was compiled through analysis, and the findings were reported in terms of frequencies and percentages. A multivariate logistic regression analysis was conducted to examine the association between the predictor variables and the outcome measure. Associations were evaluated using odds ratios (ORs) with their corresponding 95% confidence intervals (CIs). Results: Among patients with depressive disorders, the antidepressant adverse effects were observed in 82.9% of cases, with a 95% CI of 79.6–86.7. The most common adverse effects were weight gain (64%), nausea and vomiting (51%), dry mouth (49%), and headache (41%). Female was associated with a threefold increased risk of antidepressant drug adverse effects (AOR = 3.56, 95% CI: 2.73, 5.43). Additionally, being unemployed (AOR = 1.35, 95% CI: 1.30, 6.52), having a monthly income of 620 Ethiopian Birr (AOR = 4.53, 95% CI: 4.24, 9.58), limited physical activity (AOR = 4.52, 95% CI: 3.47, 11.87, and AOR = 3.03, 95% CI: 1.92, 4.32), consuming alcohol (AOR = 1.23, 95% CI: 1.20, 3.03), and using drugs for more than 2 years (AOR = 1.37, 95% CI: 1.25, 3.58) were significantly linked to antidepressant drug adverse effects in patients with depressive disorders. Conclusion: Depressive disorder treatment often encounters side effects from antidepressants. Women who are unemployed, have a monthly income of less than 620 Ethiopian Birr, engage in a limited level of physical activity, consume alcohol, and have used drugs for more than 2 years experienced significant adverse effects from antidepressants.


  • Open Access

    Prevalence and determinants of antidepressant non-adherence among patients with major depressive disorder in Ethiopia: a multi-center cross sectional study

    by Gashaw Sisay Chanie, Eyayaw Ashete Belachew, Liknaw Workie Limenh, Alemante Tafese Beyna, Assefa Kebad Mengesha, Zemenu Wube Bayleyegn, Mihret Melese, Jember Azanaw, Ashenafi Kibret Sendekie, Wudneh Simegn

    Non-adherence to antidepressant medication is a well-established factor contributing to treatment failure among patients with major depressive disorder. Addressing this issue is crucial not only for enhancing individual patient outcomes but also for alleviating the broader public health burden. The study aimed to assess antidepressant medication non-adherence and its determinants among patients with major depressive disorder at public hospital psychiatric clinics in Ethiopia. Between June 12, 2024, and November 13, 2024, a multicenter cross-sectional study was conducted at public hospital psychiatric clinics in Ethiopia. Antidepressant non-adherence was assessed using a self-reported tablet count tool with pharmacy refill records available in patients’ charts at the time of the interview. The severity of adverse drug reactions (ADRs) was evaluated using the Antidepressant Side-Effect Checklist (ASEC), while the Naranjo ADR Probability Scale was employed to determine the likelihood of ADRs. Data analysis was performed using SPSS version 26.0. Frequencies and percentages, were used to describe the characteristics of study participants. For factors associated with antidepressant non-adherence, multivariate logistic regression was conducted. The association between explanatory variable and non-adherence was assessed using odds ratios (ORs) with 95% CIs. The prevalence of antidepressant medication non-adherence was 139 (32.9%). Female gender [AOR = 3.29, 95% CI (2.04, 5.31)], illiteracy [AOR = 2.17, 95% CI (1.35, 3.50)], unemployment [AOR = 3.40, 95% CI (2.15, 5.38)], treatment duration greater than 25 months [AOR = 1.89, 95% CI (1.05, 3.41)], and severe ADRs [AOR = 3.94, 95% CI (1.68, 9.23)] were significantly associated with Antidepressant medication non-adherence. Being female, illiterate, unemployed, having a treatment duration of more than 25 months, and experiencing severe adverse drug reactions were significantly associated with non-adherence. These findings highlight the need for targeted interventions to improve adherence among these high-risk groups.


  • Open Access

    Patients reported neuropsychiatric adverse events and associated factors among PLHIV patients receiving DTG-based regimen antiretroviral therapy real-life clinical practice in Ethiopia: multi center crossetional study

    by Gashaw Sisay Chanie, Eyayaw Ashete Belachew, Abdulwase Mohammed Seid, Liknaw Workie Limenh, Melese Legesse Mitku, Alemante Tafese Beyna, Assefa Kebad Mengesha, Mihret Melese, Dereje Esubalew, Yibeltal Yismaw Gela, et al.

    Dolutegravir-based antiretroviral therapy has established itself as a key component for treating individuals with HIV. In reality, clinical settings in resource-poor areas like Ethiopia often face difficulties when using dolutegravir-based treatment due to neuropsychiatric side effects, which can not only reduce the therapy’s effectiveness but also lead to non-adherence, switching, diminished therapeutic outcomes and discontinuation. This research aimed to determine the prevalence and factors related to neuropsychiatric side effects among people living with HIV who recently began receiving Dolutegravir-based Antiretroviral Therapy in real-life clinical settings in Ethiopia. A multicenter cross-sectional study was conducted from December 1, 2023, to August 30, 2023, peoples with HIV who were initiating a Dolutegravir-based regimen for the first time. Data collection was conducted using a structured questionnaire designed to gather sociodemographic, clinical characteristics, and neuropsychiatric adverse effects from patient interviews and medical records. Bivariate and multivariate analyses were employed to identify variables significantly associated with neuropsychiatric adverse events, with P-value of ≤ 0.05. A total of 620 participants were included in the analysis, revealing a 28.3% prevalence of neuropsychiatric adverse events. The most commonly reported events were depression, insomnia, and aggressive mood. Being female [AOR = 1.72], age between 47 and 54 years [AOR = 3.8] and 55–75 years [AOR = 1.27], unemployment status [AOR = 1.35], lack of physical activity [AOR = 3.6], and minimal of physical activity [AOR = 2.4], duration since DTG-based regimen initiation, 6–12 months[AOR = 3.35], and 13–24 months [AOR = 2.67], WHO clinical stage II [AOR = 3.65], III and IV [AOR = 4.21], Detectable viral load level at the start therapy [AOR = 1.24 (1.97.6–2.05)] were significantly associated with neuropsychiatric adverse events. Being female, aged 47–75 years, unemployed, engaged in minimal or no physical activity, having a treatment duration of 6–24 months, advanced disease stage (WHO stage II-IV) and had a detectable viral load at the start of therapy. Monitoring these groups for neuropsychiatric adverse events is essential to facilitate timely interventions and improve patient outcomes.


  • Open Access

    Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia

    by Gashaw Sisay Chanie, Wagaye Atalay, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Yonas Sisay Aragie, Gizachew Kassahun Bizuneh, Mihret Melese, Rahel Belete Abebe

    Background: The incidence and nature of excessive weight gain associated with antiretroviral treatment using tenofovir, lamivudine, and dolutegravir based regimens among patients living with human immunodeficiency virus has not been properly examined in Ethiopia. Therefore, this study aimed to assess the incidence and factors associated with excessive weight gain among People living with human immunodeficiency virus on tenofovir, lamivudine, and dolutegravir based regimens in a real-world setting.Method: A multicenter retrospective cross-sectional study was conducted from December 1, 2022, to August 30, 2023, involving 620 human immunodeficiency virus patients initiating a tenofovir, lamivudine, and dolutegravir based regimen. Data on sociodemographic, clinical details, and excessive weight gain were collected from medical records and patient interviews using a semi-structured questionnaire. Continuous variables were reported with mean and standard deviation. Binary logistic regression analysis was performed, and variables with a P-value ≤0.25 were included in multivariate logistic regression. Statistical significance was set at a P-value of ≤0.05.Results: A total of 620 participants were involved in the analysis, revealing a 31.43% incidence of excessive weight gain 95%CI (27.1–36.0). The mean weight gain was 3.77 kg with a 1.5 SD at 72 months follow-up. Factors such as being female [AOR = 1.75, 95% CI (1.01, 3.04)], age between 38–46 years [AOR = 1.53, 95% CI (1.23, 2.76)], lack of physical activity were [AOR = 4.41, 95% CI (1.46, 11.80)], having 6–12 months and 13–24 months of since starting new regimen follow up duration [AOR = 3.35, 95% CI (2.79, 4.30)] and [AOR = 2.67, 95% CI (2.43, 3.25)] respectively and having detectable viral load at initiation of regimen [AOR = 2.34, 95% CI (1.18, 6.63)] were significantly associated with excessive weight gain.Conclusion: PLHIV receiving a tenofovir, lamivudine, and dolutegravir based regimen particularly females, aged 38–54 years, those with limited physical activity, follow-up durations of 6–24 months, advanced disease stages, and a detectable viral load at therapy initiation should be closely monitored for weight gain. Proactive surveillance in these patient groups is crucial to optimize therapeutic outcomes and address potential health concerns associated with weight changes.


  • Open Access

    Cosmetics Utilization Pattern, Perceived Adverse Effects and Identified Factors Among Final Year Under Graduate Female Students, University of Gondar, Ethiopia

    by Gashaw Sisay Chanie, Wudneh Simegn, Muhammed Gedu, Tigist Nega, Netsanet Chekol, Zewdu Birhanu

    Objective: The current study aimed to assess the prevalence of cosmetics utilization and perceived adverse effects among female final‐year undergraduate students at the University of Gondar, northwest Ethiopia. Methods: An institutional‐based cross‐sectional study was carried out from October 2023 to May 2024. We used stratified, simple random sampling techniques to select study participants. Data were collected by using a self‐administered questionnaire administered to trained graduate pharmacist students. EPI Info 7.1 was used for data entry, and SPSS version 26 was used for the data analysis. Descriptive statistics have been done for percentages and frequencies. We used bivariate and multiple logistic regressions to identify factors. Those variables with p < 0.05 were declared to be associated factors for the prevalence of cosmetics utilization and perceived adverse effects. Results: A total of 403 study participants were included, with a response rate of (96%). In the current study, 81% of the students were using cosmetics, and 55.6% were exposed to cosmetics‐related adverse reactions, primarily skin rash (41%) and itching (38.3%). The most frequently used cosmetic products were toothpaste, lipstick, deodorant, and perfume, which accounted for 83.7%, 56.8%, and 24.7%, respectively. Lower age (20–25 years) AOR = 5.62, urban residence AOR = 1.97, health‐related department AOR = 2.46, economic income 501–1000 Ethiopian birr AOR = 4.05, not love engaged AOR = 3.65, and 3 and 4 years of study AOR = 2.96, with a 95% CI, were significantly associated with cosmetic usage for the students. Shampoos and conditioners AOR = 3.42; hair dye use AOR = 3.40; read information from the container AOR = 2.11; add water or other agents to cosmetics AOR = 2.26; and test Cosmetic adverse reactions AOR = 4.10, with a 95% CI, were significantly associated with cosmetics‐related adverse effects. Conclusion: A significant proportion of the users suffered from cosmetic‐related adverse reactions. The health care system should be restructured to consider rational cosmetic utilization practices and prevent adverse health effects.


  • Open Access

    Pharmacy services and psychiatric patient satisfaction among community-based health insurance users in Ethiopia

    by Gashaw Sisay Chanie, Wagaye Atalay, Tekletsadik Tekleslassie Alemayehu, Zemenu Wube Bayleyegn, Gebresilassie Tadesse, Setegn Fentahun, Yilkal Abebaw Wassie, Tegenu Chanie Tesfaye, Gebremariam Wulie Geremew

    Background: The development of community-based health insurance (CBHI) was driven by the need to provide economic protection for the poor against unexpected healthcare expenses. This can lead to increased patient satisfaction with their overall care. Maintaining high levels of client satisfaction with pharmacy services is crucial for effectively treating patients with psychiatric disorders. Therefore, the purpose of this study was to assess the impact of pharmacy services on psychiatry patient satisfaction among users of CBHI in the psychiatric setting.Methods: A multicenter cross-sectional study was conducted at the psychiatric clinics with a systematic random sampling technique between December 2023 and May 2024. A structured interview questionnaire was used to gather data. Both bivariate and multivariate analysis were employed. In multivariate analysis, variables having a p-value of < 0.05 were deemed statistically significant.Result: A total of 420 participants were enrolled with a response rate of 99.5%. Overall, 261 (62.1%) of the patients reported being satisfied with the pharmacy service. However, a significant number of patients expressed dissatisfaction with certain aspects of the service, such as pharmacist counseling on medication side effects (43.1%), medication interactions (36.9%), and labeling and dispensing of medicines (42.4%). According to the study, living in an urban area [AOR = 2.0; 95% CI (1.25, 3.2); P = 0.04], being between the ages of 18–35 and 36–44 [AOR = 2.7, 95% CI (1.38, 5.3), p = 0.04] and [AOR = 3.3, 95% CI (1.6, 5.7), p = 0.001] respectively. First and second visits to the institution [AOR = 2.2; 95% CI (1.15, 4.4); P = 0.01] and [AOR = 1.9; 95% CI (1.13, 3.3); P = 0.01] respectively. Having two psychiatric disorders [AOR = 1.8, 95% CI (1.07, 3.07), p = 0.02] and all drug availability [AOR = 1.5, 95% CI (1.3, 3.43), p = 0.02], were positively associated with psychiatry patient pharmacy service satisfaction.Conclusion: In this study, the users of CBHI psychiatric patients were generally satisfied with the pharmacy service. Additionally, being urban residency age (18–44 years), first and second visits to the institution, having two psychiatric disorders and all drug availability were found to have a significant impact on psychiatric patient pharmacy services satisfaction.


  • Open Access

    Assessment of practice and perceptions of healthcare professionals regarding the contribution of inappropriate pharmaceutical compounding to adverse drug events (ADEs) and antimicrobial resistance (AMR)

    by Wondim Ayenew, Teshome Bitew, Abdulwase Mohammed, Assefa Kebad Mengesha, Gashaw Sisay Chanie, Melese Legesse Mitku, Yibeltal Yismaw Gela, Alemante Tafese Beyna, Dereje Esubalew, Wudneh Simegn, et al.